Fatal Hyocardial Infarction Associated with Sub-Clinical Doses of Imipramine *

Edwards A. L. : Imipramine myocardial toxicity. N.Y. J. Med. 64: 1979–1982, 1964.

Freyhan F. A. : Clinical effectiveness of Tofranil in the treatment of depressive psychoses. Canad. Psychiat. Ass. J. 4(Suppl.): 86–99, 1959.

Hafliger F. : Chemistry of Tofranil. Canad. Psychiat. Ass. J. 4(Suppl.): 86–89, 1959.

Kristiansen E. S. : Cardiac complications during treatment with imipramine. Acta Psychiat.-Neurol. Scand. 36: 427–442, 1961.

Kuhn R. : Uber die Behandlung Depressiver Zustande mit einem iminodibenzvlderivat (G22355). Schweiz. Med. Wschr. 87: 1135–1140, 1957.

Lehmann H. E. , Cahn C. H. , and de Verteuil R. L. : The treatment of depressive conditions with imipramine (G22355). Canad. Psychiat. Ass. J. 3: 155–164, 1958.

Malitz S. , Wilkens B. , and Esecover H. : Preliminary evaluation of Tofranil in a combined in-patient and out-patient setting. Canad. Psychiat. Ass. J. 4(Suppl.): 152, 158, 1959.

Mann A. M. , Catterson A. G. , and Macpherson A. S. : Toxicity of imipramine: Report on serious side-effects and massive overdosage. Canad. Med. Ass. J. 81: 23–28, 1959.

Mann A. M. : Cardiovascular effects of imipramine, J. Pharmacol. and Exper. Ther. 141: 237–243, 1963.

Sarwer-Foner G. J. , Grauer H. , Mackay J. , and Koranyi E. K. : Depressive states and drugs, a study of the use of imipramine “Tofranil” in open psychiatric settings. Med. Serv. J. Canad. 15: 359–382, 1959.

Sigg E. B. : Pharmacological studies with Tofranil. Canad. Psychiat. Ass. J. 4: 75–85, 1959.

Sloman L. : Myocardial infarction during imipramine treatment of depression. Canad. Med. Ass. J. 82: 20–22, 1960.